# FDA Inspection 1000396 - PharmaZell Schweiz GmbH - January 19, 2017

Source: https://www.keypedia.com/records/fda_inspections/pharmazell-schweiz-gmbh/f5827bd8-9dbf-4c95-be00-db99c5516ff0
Source feed: FDA_Inspections

> FDA Inspection 1000396 for PharmaZell Schweiz GmbH on January 19, 2017. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1000396
- Company Name: PharmaZell Schweiz GmbH
- Inspection Date: 2017-01-19
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

Company: https://www.keypedia.com/companies/pharmazell-schweiz-gmbh/106dcaa7-76a3-4d8f-a12c-29c68bb20032

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c